ProCE Banner Activity

How New Data From CROI 2017 May Renew Interest in NNRTIs

Clinical Thought
How do phase III data on doravirine affect the potential for future therapy with NNRTIs?

Released: April 21, 2017

Expiration: April 20, 2018

No longer available for credit.

Share

Faculty

Charles B. Hicks

Charles B. Hicks, MD

Professor of Medicine
Duke University Medical Center
Durham, North Carolina

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

ViiV Healthcare

Faculty Disclosure

Primary Author

Charles B. Hicks, MD

Professor of Medicine
Duke University Medical Center
Durham, North Carolina

Charles B. Hicks, MD, has disclosed that he has received consulting fees from Janssen, Merck, and ViiV and royalties from UpToDate, Inc.